Decentralized Approach to Autologous Cell Therapy Manufacturing – Advantages of Harmonized TILs Manufacturing at a Point of Care

Time: 9:30 am
day: Day Two


• Maintaining high quality by harmonized approach at decentralized Point of Care

• Increasing TIL therapy accessibility using mobile processing units for global deployment and scale out

• Developing a closed system for TIL manufacturing at point of care to both reduce contamination risk and production cost